Authors:Daniel G. Jovin, Karl G. Katlaps, Ben K. Ellis, and Benita Dharmaraj
mortality risk led to its removal from clinical use [ 61 ].
Beta-blockers are an existing therapy used to reduce blood pressure, which have properties that may make them effective neuroprotectants. They have established efficacy for hemodynamic
Authors:Ziya Totonchi, Shirin Salajegheh, Mahmoud Reza Mohaghegh, MehrdadMesbah Kiaei, Mohammad Shirvani, and Masoud Ghorbanlo
use, and cardiovascular medications such as beta-blockers, calcium channel blockers, and angiotensin-converting enzyme (ACE) inhibitors and diuretics ( P > 0.05) (Table I ) .
Patients demographic and
Ubbink, D. T., Verhaar, E. E., Lie, H. K. és mtsa:
Effect of beta-blockers on peripheral skin microcirculation in hypertension and peripheral vascular disease. J. Vasc. Surg., 2003,
Lie H. K
Psaty, B. M., Koepsell, T. D., Wagner, E. H., et al.: The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA, 1990, 263 , 1653–1657.
Wagner E. H